Mimedx (MDXG) Inventory Average (2011 - 2026)
Mimedx's (MDXG) quarterly Inventory Average came in at $25.8 million in Q1 2026, up 7.71% year-on-year from $23.9 million in Q1 2025, and down 0.53% quarter-over-quarter from $25.9 million in Q4 2025.
Mimedx (MDXG) Inventory Average (2011 - 2026) Analysis & Trends
Mimedx has disclosed Inventory Average across 15 years of filings, most recently posting $25.8 million for Q1 2026.
- Inventory Average for Q1 2026 came in at $25.8 million, up 7.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.8 million (up 7.71% YoY), and the FY2025 annual result was $24.6 million, up 9.63% from the prior year.
- Inventory Average came in at $25.8 million for Q1 2026 at Mimedx, down from $25.9 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $25.9 million in Q4 2025 to a low of $12.3 million in Q1 2022.
- The 5-year median for Inventory Average is $22.7 million (2024), against an average of $20.1 million.
- Across the five-year window, Inventory Average soared 63.34% in 2024 and retreated 1.11% in 2025, its largest moves.
- Mimedx's Inventory Average stood at $13.6 million in 2022, then surged by 47.61% to $20.0 million in 2023, then grew by 19.87% to $24.0 million in 2024, then advanced by 7.88% to $25.9 million in 2025, then fell by 0.53% to $25.8 million in 2026.
- The last three Inventory Average figures came in at $25.8 million (Q1 2026), $25.9 million (Q4 2025), and $25.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | 25.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.78 Mn |
| Dec 31, 2025 | 25.92 Mn |
| Sep 30, 2025 | 25.70 Mn |
| Jun 30, 2025 | 24.48 Mn |
| Mar 31, 2025 | 23.94 Mn |
| Dec 31, 2024 | 24.03 Mn |
| Sep 30, 2024 | 24.65 Mn |
| Jun 30, 2024 | 24.76 Mn |
| Mar 31, 2024 | 22.74 Mn |
| Dec 31, 2023 | 20.04 Mn |
| Sep 30, 2023 | 17.94 Mn |
| Jun 30, 2023 | 15.74 Mn |
| Mar 31, 2023 | 13.92 Mn |
| Dec 31, 2022 | 13.58 Mn |
| Sep 30, 2022 | 13.68 Mn |
| Jun 30, 2022 | 13.28 Mn |
| Mar 31, 2022 | 12.28 Mn |
| Dec 31, 2021 | 11.29 Mn |
| Sep 30, 2021 | 10.67 Mn |
| Jun 30, 2021 | 10.86 Mn |